BPC-157 - NutraPedia
Back to Table of Contents
BPC 157 Overview
1) What conditions has it been studied for?
BPC 157 has been studied for a variety of conditions, including:
- Gastrointestinal disorders such as ulcers and inflammatory bowel disease.
- Neurological disorders, including traumatic brain injury and nerve damage.
- Cardiovascular conditions like myocardial infarction and arrhythmias.
- Musculoskeletal issues, including tendon, ligament, and muscle injuries.
- Drug-induced damages, particularly from NSAIDs, alcohol, and amphetamines.
2) Does it work in treating those conditions?
Research indicates that BPC 157 may be effective in treating these conditions, particularly in animal models. It has shown promise in healing ulcers, reducing inflammation, and promoting muscle and tendon healing. However, more clinical studies in humans are needed to confirm these findings.
3) What health benefits does it have?
Health benefits of BPC 157 may include:
- Promoting wound healing and tissue regeneration.
- Protecting and healing gastrointestinal tract injuries.
- Neuroprotective effects in brain injuries and neurodegenerative diseases.
- Improving cardiovascular health by aiding in vascular repair.
- Enhancing recovery from musculoskeletal injuries.
4) Does it have any downsides?
Currently, the research on BPC 157 is limited, and its safety profile in humans is not fully understood. Potential downsides may include:
- Lack of extensive clinical trials to assess long-term safety and side effects.
- Potential for allergic reactions or adverse effects, though these have not been widely reported.
- Regulatory status and availability may vary by region.
5) Is it beneficial or harmful for any particular genetic variations?
As of now, there is limited research on the interaction of BPC 157 with specific genetic variations. Therefore, it is not clear if it is particularly beneficial or harmful for individuals with certain genetic makeups. More research is required to determine any genetic interactions.
Key Research Points:
- BPC 157 and Amphetamine-induced Behavior Disturbances: BPC 157 attenuates chronic amphetamine-induced behavioral disturbances in rats, including stereotyped behavior and heightened startle response. It shows a modulatory effect on the dopamine system, suggesting potential use in chronic amphetamine disturbances.
- Gastric Cytoprotection and Organoprotection: BPC 157 is identified as a mediator of stomach cytoprotection and organoprotection. It protects gastric cells and maintains integrity against noxious agents. Its effects extend to other organs, indicating potential for wound healing and endothelial protection.
- Serotonin Syndrome and Hepatotoxicity: The peptide is effective against serotonin syndrome in rats, and shows hepatoprotective effects against paracetamol toxicity. It counteracts severe liver and brain damage induced by high doses of paracetamol.
- Insulin Overdose and Ethanol Administration: BPC 157 counters effects of insulin overdose, including seizures and liver damage, and attenuates both acute and chronic alcohol-induced lesions.
- NO-system and NSAIDs Toxicity: The peptide interacts with the nitric oxide (NO) system and offers protective effects against toxicity induced by nonsteroidal anti-inflammatory drugs (NSAIDs).
- Vascular and Heart Disorders: BPC 157 shows promising results in treating heart disorders, myocardial infarction, arrhythmias, and thrombosis. It enhances angiogenesis and vascular recruitment, aiding in healing various organs.
- Neuroprotective Effects: It has neuroprotective effects on the central nervous system, counteracting damages from spinal cord injuries, stroke, and schizophrenia-like symptoms.
- Musculoskeletal Healing: The peptide enhances healing of ligament, tendon, and muscle injuries, showing potential as a therapeutic agent in musculoskeletal disorders.
- Wound Healing and Tissue Regeneration: BPC 157 promotes wound healing and tissue regeneration, including skin, tendon, and ligament healing. It influences various growth factors and pathways involved in these processes.
- Specific Case Studies: The document includes specific case studies and experimental setups, demonstrating the efficacy of BPC 157 in various models of injury and disease, both in animal models and clinical settings.
Overall, the papers below provide extensive evidence of the therapeutic potential of BPC 157 across a wide range of applications, from organ protection and wound healing to counteracting drug-induced damages and aiding in musculoskeletal recovery. The peptide's effects are attributed to its modulation of multiple molecular pathways and its broad-spectrum cytoprotective properties.
- Pentadecapeptide BPC 157 attenuates chronic amphetamine-induced behavior disturbances
- Stable Gastric Pentadecapeptide BPC 157, Robert's Stomach Cytoprotection/Adaptive Cytoprotection/Organoprotection, and Selye's Stress Coping Response: Progress, Achievements, and the Future
- Cytoprotective gastric pentadecapeptide BPC 157 resolves major vessel occlusion disturbances, ischemia-reperfusion injury following Pringle maneuver, and Budd-Chiari syndrome
- Gastric pentadecapeptide BPC 157 effective against serotonin syndrome in rats
- High hepatotoxic dose of paracetamol produces generalized convulsions and brain damage in rats. A counteraction with the stable gastric pentadecapeptide BPC 157 (PL 14736)
- Over-dose insulin and stable gastric pentadecapeptide BPC 157. Attenuated gastric ulcers, seizures, brain lesions, hepatomegaly, fatty liver, breakdown of liver glycogen, profound hypoglycemia and calcification in rats
- The influence of gastric pentadecapeptide BPC 157 on acute and chronic ethanol administration in mice
- The influence of gastric pentadecapeptide BPC 157 on acute and chronic ethanol administration in mice. The effect of N(G)-nitro-L-arginine methyl ester and L-arginine
- Toxicity by NSAIDs. Counteraction by stable gastric pentadecapeptide BPC 157
- Novel Cytoprotective Mediator, Stable Gastric Pentadecapeptide BPC 157. Vascular Recruitment and Gastrointestinal Tract Healing
- Brain-gut Axis and Pentadecapeptide BPC 157: Theoretical and Practical Implications
- Stable Gastric Pentadecapeptide BPC 157 Therapy of Rat Glaucoma
- Stable Gastric Pentadecapeptide BPC 157 and Striated, Smooth, and Heart Muscle
- Stable Gastric Pentadecapeptide BPC 157 as Useful Cytoprotective Peptide Therapy in the Heart Disturbances, Myocardial Infarction, Heart Failure, Pulmonary Hypertension, Arrhythmias, and Thrombosis Presentation
- Pentadecapeptide BPC 157 efficiently reduces radiation-induced liver injury and lipid accumulation through Kruppel-like factor 4 upregulation both in vivo and in vitro
- Gastric pentadecapeptide BPC 157 accelerates healing of transected rat Achilles tendon and in vitro stimulates tendocytes growth
- Achilles detachment in rat and stable gastric pentadecapeptide BPC 157: Promoted tendon-to-bone healing and opposed corticosteroid aggravation
- Pentadecapeptide BPC 157 (PL 14736) improves ligament healing in the rat
- BPC 157 and Standard Angiogenic Growth Factors. Gastrointestinal Tract Healing, Lessons from Tendon, Ligament, Muscle and Bone Healing
- Novel Therapeutic Effects in Rat Spinal Cord Injuries: Recovery of the Definitive and Early Spinal Cord Injury by the Administration of Pentadecapeptide BPC 157 Therapy
- Therapy Effect of the Stable Gastric Pentadecapeptide BPC 157 on Acute Pancreatitis as Vascular Failure-Induced Severe Peripheral and Central Syndrome in Rats
- Stable Gastric Pentadecapeptide BPC 157 Heals Established Vesicovaginal Fistula and Counteracts Stone Formation in Rats
- Pentadecapeptide BPC 157 and the central nervous system
- Intra-Articular Injection of BPC 157 for Multiple Types of Knee Pain
- Stable Gastric Pentadecapeptide BPC 157 and Wound Healing
- The effect of pentadecapeptide BPC 157 on hippocampal ischemia/reperfusion injuries in rats
- BPC 157 Rescued NSAID-cytotoxicity Via Stabilizing Intestinal Permeability and Enhancing Cytoprotection
- Fistulas Healing. Stable Gastric Pentadecapeptide BPC 157 Therapy
- Intragastric Application of Aspirin, Clopidogrel, Cilostazol, and BPC 157 in Rats: Platelet Aggregation and Blood Clot
- Gastric pentadecapeptide body protection compound BPC 157 and its role in accelerating musculoskeletal soft tissue healing
- BPC 157 counteracts QTc prolongation induced by haloperidol, fluphenazine, clozapine, olanzapine, quetiapine, sulpiride, and metoclopramide in rats
- Nonsteroidal anti-inflammatory drugs-induced failure of lower esophageal and pyloric sphincter and counteraction of sphincters failure with stable gatric pentadecapeptide BPC 157 in rats
- Therapeutic potential of pro-angiogenic BPC157 is associated with VEGFR2 activation and up-regulation
- Stable gastric pentadecapeptide BPC 157 and bupivacaine
- Body protective compound-157 enhances alkali-burn wound healing in vivo and promotes proliferation, migration, and angiogenesis in vitro
- The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration
- Pentadecapeptide BPC 157 enhances the growth hormone receptor expression in tendon fibroblasts
- BPC 157 and blood vessels
- Modulatory effect of gastric pentadecapeptide BPC 157 on angiogenesis in muscle and tendon healing
- Focus on ulcerative colitis: stable gastric pentadecapeptide BPC 157
- High hepatotoxic dose of paracetamol produces generalized convulsions and brain damage in rats. A counteraction with the stable gastric pentadecapeptide BPC 157 (PL 14736)
- Gastric pentadecapeptide BPC 157 counteracts morphine-induced analgesia in mice
- Antiinflammatory effect of BPC 157 on experimental periodontitis in rats
- Over-dose insulin and stable gastric pentadecapeptide BPC 157. Attenuated gastric ulcers, seizures, brain lesions, hepatomegaly, fatty liver, breakdown of liver glycogen, profound hypoglycemia and calcification in rats
- Impact of pentadecapeptide BPC 157 on muscle healing impaired by systemic corticosteroid application
- Revised Robert's cytoprotection and adaptive cytoprotection and stable gastric pentadecapeptide BPC 157. Possible significance and implications for novel mediator
- The pharmacological properties of the novel peptide BPC 157 (PL-10)
- The stable gastric pentadecapeptide BPC 157, given locally, improves CO2 laser healing in mice
- Corticosteroid-impairment of healing and gastric pentadecapeptide BPC-157 creams in burned mice
- The antidepressant effect of an antiulcer pentadecapeptide BPC 157 in Porsolt's test and chronic unpredictable stress in rats. A comparison with antidepressants
- The effect of a novel pentadecapeptide BPC 157 on development of tolerance and physical dependence following repeated administration of diazepam
- BPC 157's effect on healing
Upload raw DNA data to get started with your free DNA raw data analysis today!